Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

It is uncommon to have off label use covered. H

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153965
(Total Views: 314)
Posted On: 11/19/2019 9:49:19 AM
Posted By: docj
Re: IndexGuy #11124
It is uncommon to have off label use covered.

Here is 8/1/19 UHC's policy:

2. Off-label Drug Use, means the use of a drug for the purpose that is different from the use for
which the drug has been approved by the Food and Drug Administration (FDA)including offlabel self-injectable drugs, only when all of the following criteria are met:
a. The drug is approved by the FDA (for label usage);
b. The drug is prescribed by a Network/contracting provider for the treatment of a lifethreatening condition or for a chronic and seriously debilitating condition;
c. The drug is medically necessary to treat the condition;
d. The member has failed, is intolerant of, or has contraindications to standard therapies;
e. The drug has been recognized for treatment of the life-threatening or chronic and
seriously debilitating condition by one of the following: The American Hospital Formulary
Service Drug Information, DRUGDEX System by Micromedex, The United States
Pharmacopoeia Dispensing Information or in two articles from major peer-reviewed
medical journals that present data supporting the proposed Off-Label Drug Use or uses
as generally safe and effective unless there is clear and convincing contradictory
evidence presented in a major peer reviewed medical journal;
f. The drug is covered under the member’s injectable drug benefit described in the
outpatient benefits section of the member’s EOC


(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us